Advertisement
Screener

G1 THERAPEUTICS, INC. Long-Term Debt, Maturity, Year Five

G1 THERAPEUTICS, INC. Long-Term Debt, Maturity, Year Five

G1 THERAPEUTICS, INC. had Long-Term Debt, Maturity, Year Five of $36.20 million as of 2022-03-31, per its 10-Q filed 2022-05-04.

Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2022-05-04

  • 2022-03-31: Long-Term Debt, Maturity, Year Five $36.20M.
  • 2021-12-31: Long-Term Debt, Maturity, Year Five $36.15M.
  • 2021-09-30: Long-Term Debt, Maturity, Year Five $6.64M.
  • 2021-06-30: Long-Term Debt, Maturity, Year Five $6.64M.
Period endLong-Term Debt, Maturity, Year Five
2022-03-31$36.20M
10-Q · filed 2022-05-04
2021-12-31$36.15M
10-K · filed 2022-02-23
2021-09-30$6.64M
10-Q · filed 2021-11-03
2021-06-30$6.64M
10-Q · filed 2021-08-04
2021-03-31$6.64M
10-Q · filed 2021-05-05